International Journal of Molecular Medical Science, 2025, Vol.15, No.4, 165-174 http://medscipublisher.com/index.php/ijmms 173 Gao J., Lun P., Ding Y., and George P., 2022, COVID-19 vaccination for frail older adults in singapore-rapid evidence summary and delphi consensus statements, The Journal of Frailty and Aging, 11: 236-241. https://doi.org/10.14283/jfa.2022.12 Gao Z., Feng Y., Xu J., and Liang J., 2022, T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy, Frontiers in Immunology, 13: 977394. https://doi.org/10.3389/fimmu.2022.977394 Gasmi A., Mujawdiya K., Noor S., Piscopo S., Résimont S., and Menzel A., 2022, Increasing efficacy of Covid-19 vaccines by lifestyle interventions, Archives of Razi Institute, 77(5): 1527-1538. https://doi.org/10.22092/ARI.2021.356491.1854 Goudsmit J., Van Den Biggelaar A., Koudstaal W., Hofman A., Koff W., Schenkelberg T., Alter G., Mina M., and Wu J., 2021, Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the human immunomics initiative research program, European Journal of Epidemiology, 36: 753-762. https://doi.org/10.1007/s10654-021-00767-z Gualano B., Sieczkowska S., Lemes Í., Da Silva R., Pinto A., Mazzolani B., Smaira F., Aikawa N., Kupa L., Pasoto S., Medeiros-Ribeiro A., Saad C., Yuk E., Silva C., Swinton P., Hallal P., Roschel H., and Bonfá E., 2023, Physical activity: a strategy to improve antibody response to a SARS-CoV-2 vaccine booster dose in patients with autoimmune rheumatic diseases, Journal of Physical Activity and Health, 20(4): 311-316. https://doi.org/10.1123/jpah.2022-0332 Hodges R., and Lamotte A., 2022, Impact of diet and lifestyle on vaccine efficacy in adults aged 55 and older: a review, Integrative Medicine, 21(4): 32-52. Honce R., Vazquez-Pagan A., Livingston B., Mandarano A., Wilander B., Cherry S., Hargest V., Sharp B., Brigleb P., Roubidoux E., Van De Velde L., Skinner R., McGargill M., Thomas P., and Schultz-Cherry S., 2024, Diet switch pre-vaccination improves immune response and metabolic status in formerly obese mice, Nature Microbiology, 9(6): 1593-1606. https://doi.org/10.1038/s41564-024-01677-y Hou J., and Nakaya H., 2024, Editorial: systems immunology to advance vaccine development, Frontiers in Immunology, 15: 1527238.. https://doi.org/10.3389/fimmu.2024.1527238 Hou Y., Chen M., Bian Y., Hu Y., Chuan J., Zhong L., Zhu Y., and Tong R., 2024, Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies, NPJ Vaccines, 9(1): 77. https://doi.org/10.1038/s41541-024-00874-4 Incalzi R., Consoli A., Lopalco P., Maggi S., Sesti G., Veronese N., and Volpe M., 2023, Influenza vaccination for elderly vulnerable and high-risk subjects: a narrative review and expert opinion, Internal and Emergency Medicine, 19: 619-640. https://doi.org/10.1007/s11739-023-03456-9 Kim J., Marks F., and Clemens J., 2021, Looking beyond COVID-19 vaccine phase 3 trials, Nature Medicine, 27: 205-211. https://doi.org/10.1038/s41591-021-01230-y Lewis E., Wu D., and Meydani S., 2022, Age-associated alterations in immune function and inflammation, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 118: 110576. https://doi.org/10.1016/j.pnpbp.2022.110576 Li W., and Li Y., 2020, Chemical strategies to boost cancer vaccines, Chemical Reviews, 120(20): 11420-11478. https://doi.org/10.1021/acs.chemrev.9b00833 Mittelbrunn M., and Kroemer G., 2021, Hallmarks of T cell aging, Nature Immunology, 22: 687-698. https://doi.org/10.1038/s41590-021-00927-z Moehling K., Zhai B., Schwarzmann W., Chandran U., Ortiz M., Nowalk M., Nace D., Lin C., Susick M., Levine M., Alcorn J., and Zimmerman R., 2020, The impact of physical frailty on the response to inactivated influenza vaccine in older adults, Aging, 12: 24633-24650. https://doi.org/10.18632/aging.202207 Pereira B., Xu X., and Akbar A., 2020, Targeting inflammation and immunosenescence to improve vaccine responses in the elderly, Frontiers in Immunology, 11: 583019. https://doi.org/10.3389/fimmu.2020.583019 Qiu J., Zhang S., Feng Y., Su X., Cai J., Chen S., Liu J., Huang S., Huang H., Zhu S., Wen H., Li J., Yan H., Diao Z., Liang X., and Zeng F., 2023, Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses, Expert Review of Vaccines, 23: 69-81. https://doi.org/10.1080/14760584.2023.2289566 Ridda I., Macintyre C., Lindley R., Lindley R., Gao Z., Sullivan J., Sullivan J., Yuan F., Yuan F., and Mcintyre P., 2009, Immunological responses to pneumococcal vaccine in frail older people, Vaccine, 27(10): 1628-1636. https://doi.org/10.1016/j.vaccine.2008.11.098 Salminen A., 2021, Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions, Journal of Molecular Medicine, 99: 1553-1569. https://doi.org/10.1007/s00109-021-02123-w Salminen A., 2022, Clinical perspectives on the age-related increase of immunosuppressive activity, Journal of Molecular Medicine, 100: 697-712. https://doi.org/10.1007/s00109-022-02193-4 Semelka C., DeWitt M., Blevins M., Holbrook B., Sanders J., and Alexander-Miller M., 2023, Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults, Immunity and Ageing, 20(1): 4.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==